Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urine Assay Validation for Tenofovir Alafenamide Adherence
NCT03350672Phase 4Completed
- Sponsor
- Philadelphia FIGHT
- Start
- Nov 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Philadelphia FIGHT. Started Nov 2017; status: completed.
02
Drugs
emtricitabine + tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03350672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03350672.